Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC lessened its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 8.0% in the 4th quarter, Holdings Channel reports. The firm owned 52,958 shares of the company’s stock after selling 4,624 shares during the period. Janney Montgomery Scott LLC’s holdings in Privia Health Group were worth $1,035,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its stake in shares of Privia Health Group by 98.7% in the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after buying an additional 845 shares in the last quarter. Financial Management Professionals Inc. acquired a new position in Privia Health Group in the 4th quarter valued at about $51,000. Quarry LP increased its stake in Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after purchasing an additional 2,533 shares during the period. KBC Group NV lifted its position in shares of Privia Health Group by 34.6% during the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after purchasing an additional 871 shares in the last quarter. Finally, Neo Ivy Capital Management purchased a new position in shares of Privia Health Group in the third quarter valued at approximately $66,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA opened at $23.38 on Thursday. Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $23.62. The firm has a market capitalization of $2.81 billion, a P/E ratio of 233.82, a P/E/G ratio of 3.09 and a beta of 0.87. The company’s fifty day moving average price is $21.30 and its 200 day moving average price is $20.05.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. JPMorgan Chase & Co. upped their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th. Needham & Company LLC began coverage on Privia Health Group in a research report on Friday, January 10th. They set a “buy” rating and a $25.00 price objective on the stock. KeyCorp began coverage on Privia Health Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $23.00 price objective on the stock. Stephens reissued an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a research note on Thursday, January 2nd. Finally, Barclays increased their price target on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $24.88.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.